To assess the accuracy with which available retinopathy of prematurity (ROP) predictive models detect clinically significant ROP and to what extent and at what risk these models allow for the reduction of screening examinations for ROP.
To evaluate visual and anatomic outcomes after intravitreal aflibercept injection (IAI) versus laser in diabetic macular edema (DME) patients with and without prior anti–vascular endothelial growth factor (VEGF) treatment for DME.
A 75-year-old white man with suspected glaucoma and previously normal automated visual fields (AVF; Fig 1A) and a past medical history notable for acephalgic migraine presented to a glaucoma clinic for annual evaluation. At the beginning of the visit, the patient had no new ocular complaints. Visual acuity was 20/30 in the right eye and 20/25 in the left. Pupils were equal, round, and reactive with no afferent pupillary defect. Intraocular pressure was 21 mmHg bilaterally by applanation tonometry.
We extend our deepest gratitude to our Platinum, Gold, and Silver partners. Your generous support fuels our mission to advance medical education, advocate for patient safety, and foster breakthrough innovations across West Virginia.